Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Peripheral Blood Stem Cell Transplantation With Minimally Myelosuppressive Regimen of Pentostatin and Low-dose Total-body Irradiation

NCT00571662 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00571662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Peripheral Blood Stem Cell Transplantation With Minimally Myelosuppressive Regimen of Pentostatin and Low-dose Total-body Irradiation
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Completed
Start date
December 8, 2000
Completion date
December 30, 2008
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, hodgkins disease, multiple myeloma, myelodysplastic syndromes, non-hodgkins lymphoma, peripheral t-cell lymphoma